Transcranial magnetic stimulation (TMS) for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
StrokeTranscranial magnetic stimulation (TMS) - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is studying the effects of TMS on motor cortex excitability in people who have had a stroke, and how the phase of the oscillatory rhythm (mu frequency) affects motor excitability in stroke patients.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 3 hours

3 hours
Motor evoked potentials (MEPs)

Trial Safety

Trial Design

2 Treatment Groups

Participants With Unilateral Stroke
1 of 2
Participants Without Unilateral Stroke
1 of 2

Experimental Treatment

72 Total Participants · 2 Treatment Groups

Primary Treatment: Transcranial magnetic stimulation (TMS) · No Placebo Group · N/A

Participants With Unilateral Stroke
Device
Experimental Group · 1 Intervention: Transcranial magnetic stimulation (TMS) · Intervention Types: Device
Participants Without Unilateral Stroke
Device
Experimental Group · 1 Intervention: Transcranial magnetic stimulation (TMS) · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial magnetic stimulation (TMS)
2013
Completed Phase 4
~510

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 hours

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,256 Previous Clinical Trials
1,483,850 Total Patients Enrolled
34 Trials studying Stroke
50,691 Patients Enrolled for Stroke
Alexander Opitz, PhDPrincipal InvestigatorUniversity of Minnesota Department of Biomedical Engineering
2 Previous Clinical Trials
42 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: